Business Description
BioNote Inc
ISIN : KR7377740006
Share Class Description:
XKRX:377740: Ordinary SharesCompare
Compare
Traded in other countries / regions
377740.Korea IPO Date
2022-12-22Description
BioNote Inc is a manufacturer of diagnostic kits and equipment for animal diseases and is equipped with a wide product portfolio, from initial screening tests to molecular diagnosis. Its animal diagnostics products comprise of Vcheck F, Vcheck M, Vcheck C, Rapid, and ELISA.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 106.13 | |||||
| Equity-to-Asset | 0.97 | |||||
| Debt-to-EBITDA | 0.11 | |||||
| Interest Coverage | 21.47 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 7.19 | |||||
| Beneish M-Score | -3.09 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -49.2 | |||||
| 3-Year Book Growth Rate | 30.7 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 29.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 60.23 | |||||
| 9-Day RSI | 52.15 | |||||
| 14-Day RSI | 51.65 | |||||
| 6-1 Month Momentum % | 0.11 | |||||
| 12-1 Month Momentum % | -10.08 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 25.93 | |||||
| Quick Ratio | 24.45 | |||||
| Cash Ratio | 23.14 | |||||
| Days Inventory | 219.47 | |||||
| Days Sales Outstanding | 74.28 | |||||
| Days Payable | 22.98 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.41 | |||||
| Dividend Payout Ratio | 0.24 | |||||
| Forward Dividend Yield % | 17.62 | |||||
| 5-Year Yield-on-Cost % | 4.41 | |||||
| 3-Year Average Share Buyback Ratio | -2.9 | |||||
| Shareholder Yield % | 3.94 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 49.44 | |||||
| Operating Margin % | 15.27 | |||||
| Net Margin % | 85.88 | |||||
| FCF Margin % | 45.08 | |||||
| ROE % | 5.26 | |||||
| ROA % | 5.02 | |||||
| ROIC % | 3.97 | |||||
| 3-Year ROIIC % | -60.41 | |||||
| ROC (Joel Greenblatt) % | 21.87 | |||||
| ROCE % | 1.64 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 5.68 | |||||
| Forward PE Ratio | 27.03 | |||||
| PE Ratio without NRI | 5.53 | |||||
| PS Ratio | 4.87 | |||||
| PB Ratio | 0.29 | |||||
| Price-to-Tangible-Book | 0.3 | |||||
| Price-to-Free-Cash-Flow | 10.81 | |||||
| Price-to-Operating-Cash-Flow | 9.17 | |||||
| EV-to-EBIT | 1.91 | |||||
| EV-to-EBITDA | 1.46 | |||||
| EV-to-Revenue | 0.53 | |||||
| EV-to-FCF | 1.18 | |||||
| Price-to-Graham-Number | 0.28 | |||||
| Price-to-Net-Current-Asset-Value | 1.15 | |||||
| Price-to-Net-Cash | 1.31 | |||||
| Earnings Yield (Greenblatt) % | 52.36 | |||||
| FCF Yield % | 9.25 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BioNote Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 95,080.698 | ||
| EPS (TTM) (â‚©) | 800 | ||
| Beta | 0 | ||
| Volatility % | 29.78 | ||
| 14-Day RSI | 51.65 | ||
| 14-Day ATR (â‚©) | 232.964535 | ||
| 20-Day SMA (â‚©) | 4836.75 | ||
| 12-1 Month Momentum % | -10.08 | ||
| 52-Week Range (â‚©) | 3800 - 6400 | ||
| Shares Outstanding (Mil) | 102.06 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BioNote Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BioNote Inc Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
BioNote Inc Frequently Asked Questions
What is BioNote Inc(XKRX:377740)'s stock price today?
The current price of XKRX:377740 is â‚©4700.00. The 52 week high of XKRX:377740 is â‚©6400.00 and 52 week low is â‚©3800.00.
When is next earnings date of BioNote Inc(XKRX:377740)?
The next earnings date of BioNote Inc(XKRX:377740) is .
Does BioNote Inc(XKRX:377740) pay dividends? If so, how much?
The Dividend Yield %  of BioNote Inc(XKRX:377740) is 4.41% (As of Today), Highest Dividend Payout Ratio of BioNote Inc(XKRX:377740) was 0.24. The lowest was 0.15. And the median was 0.15. The  Forward Dividend Yield % of BioNote Inc(XKRX:377740) is 17.62%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers